Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after announcing its subsidiary Labskin has partnered with the University of Aberdeen to test anti-viral skin and dental products that might mitigate the transmission risk of the coronavirus (COVID-19).
Scientists will use Labskin’s cloned human skin coated with the SARS-CoV-2 virus in their research which will take place in a Category 3 lab at the university.